CARBOGEN AMCIS SAS Sets the Standard: GMP Certification for Saint-Beauzire Site Redefines Pharmaceutical Excellence

CARBOGEN AMCIS SAS is pleased to have acquired a GMP compliance certificate for its modern facility in Saint-Beauzire, France. The site is intended for the manufacture and sterile production of injectable drug products, both in the form of liquids and lyophilized forms. The facility accommodates two completely automated production lines, which are engineered to be compliant with the strict demands of Annex 1 and other GMP directives. This feat reiterates CARBOGEN AMCIS's dedication to upholding high-quality standards in pharmaceutical production.

 

CARBOGEN AMCIS Saint-Beauzire facility is designed to accommodate challenging formulations and highly active compounds, accommodating late-stage clinical trials and small-scale commercial production. The advanced capabilities of the site include microbiological and analytical testing, which guarantees the utmost product integrity and safety.

 

Source: Manufacturing Chemist, CARBOGEN AMCIS News